Skip to main content
. 2020 Jun 10;478(12):2812–2820. doi: 10.1097/CORR.0000000000001351

Table 1.

Distribution of patients included in the study versus excluded for loss of follow, with patient, tumor, and operative characteristics

Parameter Included patients (n = 366) Patients lost to follow-up (n = 107) Odds ratio (95% CI) or mean difference ± SD p value
Patient gendera 0.51b
 Female 45 (164) 41(44)
 Male 55 (202) 59 (63) 1.16 (0.74 to 1.8)
Patient age (years)c 59.0 (43.0 to 70.0) 63.0 (50.0 to 76.0) 0.003d
Patient BMI (kg/m2)e 28.9 ± 7.0 28.9 ± 6.9 -0.02 ± 6.95 0.98f
Largest tumor dimension (cm)c 7.0 (4.0 to 11.2) 7.5 (4.5 to 15.0) 0.32d
Categorical tumor sizea 0.71d
 ≤ 5 cm 37 (137) 41 (44)
 > 5, ≤ 10 cm 32 (118) 30 (32) 0.91 (0.54 to 1.54)
 > 10 cm 30 (111) 29 (31) 0.94 (0.55 to 1.61)
Tumor locationa 0.15b
 Lower extremity 56 (206) 67 (72)
 Upper extremity 18 (67) 18 (19) 0.79 (0.44 to 1.42)
 Back/torso/neck 10 (37) 3 (4) 0.33 (0.11 to 0.95)
 Pelvis/sacrum 9 (32) 6 (6) 0.55 (0.22 to 1.38)
 Acral (hand/foot) 7 (24) 6 (6) 0.74 (0.29 to 1.87)
Tumor deptha 0.63b
 Superficial 14 (50) 11 (12)
 Deep 86 (316) 89 (94) 1.21 (0.62 to 2.4)
Tumor gradea 0.13d
 Low 12 (43) 17 (18)
 Intermediate 2 (7) 3 (3) 0.98 (0.23 to 4.21)
 High 86 (315) 80 (86) 0.61 (0.33 to 1.11)
Tumor marginsa 0.020d
 Positive margins 29 (104) 22 (23)
 < 0.1 cm 21 (76) 18 (19) 1.15 (0.58 to 2.25)
 < 0.5 cm 20 (72) 18 (19) 1.07 (0.53 to 2.14)
 ≥ 0.5 cm 30 (111) 42 (45) 1.87 (1.06 to 3.31)
Operative closurea 0.30b
 Primary 95 (346) 93 (99)
 Flap 5 (20) 7 (8) 1.41 (0.60 to 3.3)

Data are presented as: aN (%), cmedian (IQR), or emean 6 SD; p values were calculated using the following: +Fisher's Exact test, dKruskal-Wallis test, fANOVA. p < 0.05 indicates significance.